Home/Filings/4/0001209191-21-052519
4//SEC Filing

Gros David-Alexandre C 4

Accession 0001209191-21-052519

CIK 0001404281other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:05 PM ET

Size

5.3 KB

Accession

0001209191-21-052519

Insider Transaction Report

Form 4
Period: 2021-08-17
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2021-08-17$6.21/sh+4,000$24,8407,000 total
Footnotes (1)
  • [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple open market transactions in accordance with the Issuer's trading policies at prices ranging from $6.20 to $6.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Eledon Pharmaceuticals, Inc.

CIK 0001404281

Entity typeother

Related Parties

1
  • filerCIK 0001644489

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:05 PM ET
Size
5.3 KB